Literature DB >> 22832642

Paratesticular tumors. Description of our case series through a period of 25 years.

Paola I Roman Birmingham1, F Javier Navarro Sebastian, Jesus Garcia Gonzalez, Gonzalo Romero Barriuso, Antonio Guijarro Espadas.   

Abstract

INTRODUCTION: Paratesticular tumors are masses of slow and indolent growth and in most cases of benign nature (70 %), being that the case, the treatment of choice is simple extirpation of the lesion and follow-up, based on observation only. On those identified as malignant (30 %), treatment is more complex, consisting in radical orchiectomy with adjuvant chemotherapy or radiotherapy. This work tries to describe our case series of paratesticular tumors over the last 25 years and to make a comparative analysis with the information published in the world literature.
OBJECTIVE: To describe our experience with paratesticular tumors, their incidence, demographic data and treatment over a period of 25 years.
METHODS: Descriptive study where we analyzed clinical data of 16 patients with the diagnosis of paratesticular tumor treated at Mostoles Hospital between 1984 and 2010 analyzing the age, type of tumor, treatment and follow-up.
RESULTS: Mean age was 50 years (range: 16-88), benign tumors were detected in 76 % of the cases and malignant in 24%. The tumor more frequently found in our series was leiomyoma (23.5%), with slight predominance of the right side (53 %); the most frequent location was the epididymis (50%) and mean size was 4.9 cm of diameter. The mean follow up was 34 months without complications or tumor relapse in any patient.
CONCLUSIONS: Despite only three-quarters of paratesticular tumors are non-malignant, it is always advisable to do intraoperative pathological analysis of all this masses. Having a non-malignant diagnosis, the treatment of choice is simple extirpation of the mass. In our study the majority of the tumors were diagnosed in adult age (average 51 years), the most frequent was leiomyoma and the most common location was the epididymis.

Entities:  

Mesh:

Year:  2012        PMID: 22832642

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  6 in total

1.  Bilateral Synchronous Paratesticular Leiomyoma - A Rare Entity.

Authors:  Amrit Fernandez; Sriram Krishnamoorthy; Susruthan Muralitharan; Thanka Johnson; Venkat Ramanan
Journal:  J Clin Diagn Res       Date:  2017-04-01

2.  Alveolar Paratesticular Rhabdomyosarcoma in an Adult Patient Mimicking Epididymo-Orchitis: A Case Report and a Literature Review.

Authors:  Ahmed S Al Ghamdi; Naif M Alharbi; Khalil F Miyajan; Aseel A Hazzazi; Ali A Fadel; Numan Tabba
Journal:  Cureus       Date:  2022-05-06

3.  TESTICULAR ADNEXAL MESENCHYMAL TUMOURS IN IBADAN, NIGERIA: HISTOPATHOLOGIC SPECTRUM AND CHARACTERISTICS.

Authors:  G O Ogun; A O Takure; U S Ezenkwa; I N Chibuzor
Journal:  J West Afr Coll Surg       Date:  2018 Apr-Jun

4.  Alveolar paratesticular rhabdomyosarcoma mimicing epididymitis: Case report and literature review.

Authors:  W-H Lei; Wen-Feng Wu; Jin-Yang Zhen; Yang-Hui Li; Jie Li; Jun Xin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

5.  Advantage of Adding Diffusion Weighted Imaging to Routine MRI Examinations in the Diagnostics of Scrotal Lesions.

Authors:  Ahmed Mohamed Algebally; Hazim Ibrahim Tantawy; Reda Ramadan Hussein Yousef; Wojciech Szmigielski; Adham Darweesh
Journal:  Pol J Radiol       Date:  2015-09-25

6.  Occurrence of paratesticular ganglioneuroma 18 years after concurrent adrenal ganglioneuroma and papillary thyroid carcinoma - a case report.

Authors:  Chu-Wen Fang; Jyh-Seng Wang; Tony T Wu; Jen-Tai Lin
Journal:  BMC Cancer       Date:  2019-12-30       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.